TITLE

Controversies in the cardiovascular management of type 2 diabetes

AUTHOR(S)
Opie, Lionel H.; Yellon, Derek M.; Gersh, Bernard J.
PUB. DATE
January 2011
SOURCE
Heart;Jan2011, Vol. 97 Issue 1, p6
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
In patients with type 2 diabetes mellitus, intense control of blood pressure, lipids and glucose, aiming at theoretically ideal values, is bought at a cost. Intense blood pressure control has renal complications. Intense lipid control, thus far, has worked for reduction of low-density lipoprotein-cholesterol, paradoxically at the cost of a small increase in new diabetes. Intense control of glycaemia generally requires insulin added to oral agents, which is consistently accompanied by weight gain, while increased hypoglycaemia has a long-term risk of cerebral damage. Intense glycaemic control has not consistently reduced mortality, whereas a strategy based on tight control of lipids and blood pressure with modestly tight glucose control has succeeded. Looking to the future, incretin mimetics may come to the fore as prime agents because they can reduce weight and glycaemia with little significant hypoglycaemia, thereby making tight glucose control easier to achieve.
ACCESSION #
60944898

 

Related Articles

  • Cardiovascular protection in type 2 diabetes: time to ADVANCE management ACCORDing to the evidence. Hajhosseiny, Reza; Khavandi, Kaivan; Mashayekhi, Soudeh; Greenstein, Adam S.; Malik, Rayaz A. // Research Reports in Clinical Cardiology;2014, Vol. 5, p1 

    Individuals with type 2 diabetes mellitus are at very substantial risk of cardiovascular disease, and most will succumb to complications from premature coronary artery events. At the same time, the diabetic myocardium undergoes unique phenotypic alterations as a consequence of multiple...

  • Effect of valsartan on urinary excretion. Pinkowish, Mary Desmond // Patient Care;Oct2002, Vol. 36 Issue 12, p100 

    Discusses research being done on the blood pressure-independent effect of microalbuminuria reduction with valsartan inpatients with type 2 diabetes mellitus. Reference to a study by G. Viberti et al published in the 2002 issue of "Circulation"; Methodology of the study; Results of the study.

  • ACP: Tight BP control must be top priority in diabetes management.  // Geriatrics;Jun2003, Vol. 58 Issue 6, p15 

    Cites research findings recommending that the management of type 2 diabetes mellitus include tight blood pressure control in addition to glycemic control. Need for blood pressure control to be a top priority in type 2 diabetes management to prevent the onset of cardiovascular diseases;...

  • Cardiovascular Disease.  // Current Medical Literature: Diabetes;2011, Vol. 28 Issue 2, p59 

    The article discusses research studies on the association between cardiovascular disease (CD) and diabetes. A study published in the "Journal of Clinical Pharmacology" examined long-term rosiglitazone treatment effects on CD outcomes in type 2 diabetes mellitus patients. Another study suggested...

  • Focus on Fiber, not Fat. O., J. // School Health Alert;Jan2012, Vol. 27 Issue 5, p1 

    The article offers information on metabolic syndrome (MetS), which is a physical factor associated with cardiovascular disease and type 2 diabetes. It states that MetS is also defined as blood pressure, high waist circumference, serum triglycerides and serum glucose. It mentions that its...

  • ROADMAP and ORIENTAL Trials: the Re-emergence of J-Curve Ghost? Hamamoto, Yoshiyuki; Koshiyama, Hiroyuki // Japanese Clinical Medicine;2011, Issue 2, p25 

    It still remains unknown whether angiotensin-receptor blockers (ARBs) are cardioprotective in patients with type 2 diabetes. The recent two clinical trials, the ROADMAP and the ORIENT, have suggested that fatal cardiovascular events or cardiovascular deaths were unexpectedly higher in olmesartan...

  • Diabetes Potpourri: Nomenclatured and Glycemia. Marks, Jennifer B. // Clinical Diabetes;Spring2004, Vol. 22 Issue 2, p50 

    Comments on the importance of cardiovascular risk and disease prevention which emphasized the goals of blood pressure, cholesterol and weight control in the management of type 2 diabetes. Use of the term diabetics; Importance of glycemic control in the prevention of coronary disease;...

  • Office and ambulatory pulse pressure-association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study). Januszewicz, A; Ritz, E; Viberti, G; Mimran, A; Rabelink, A J; Rump, L C; Ruilope, L M; Katayama, S; Ito, S; Izzo, J L; Haller, H // Journal of Human Hypertension;Nov2011, Vol. 25 Issue 11, p679 

    To investigate the association of office and ambulatory 24-h pulse pressure (PP) with clinical characteristics and cardiovascular risk factors in normoalbuminuric type 2 diabetic patients enrolled to the Randomised Olmesartan and Diabetes Microalbuminuria Prevention study, 4449 patients (2054...

  • Pulse pressure and systolic night-day ratio interact in prediction of macrovascular disease in patients with type 2 diabetes mellitus. Laugesen, E; Rossen, N B; Poulsen, P L; Hansen, K W; Ebbehøj, E; Knudsen, S T // Journal of Human Hypertension;Mar2012, Vol. 26 Issue 3, p164 

    Patients with type 2 diabetes mellitus are at increased risk of cardiovascular disease (CVD). We examined the predictive ability of 24-hour ambulatory pulse pressure (24-h PP), ambulatory arterial stiffness index (AASI) and diurnal blood pressure (BP) parameters for fatal and non-fatal CVD in...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics